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ABSTRACT Iatrogenic anetoderma of prematurity (IAOP) repre-
sents a benign iatrogenic dermatosis characterized by focal, well-
demarcated areas of atrophic skin in preterm infants. We present 
the cases of 5 infants diagnosed with IAOP during a 3-year pe-
riod in a tertiary-care university hospital. Skin atrophy patches 
were absent at birth in all presented infants, and there was no 
family history of anetoderma. All of the infants were born with 
very low gestation and birth weight, with a clinical course that 
was complicated with several serious prematurity-related compli-
cations with consequent long periods of unstable vital functions 
and the need for continuous monitoring. Skin defects consistent 
with IAOP were located on the previous ECG electrode sites. IAOP 
changes in all the infants were in the form of oval patches of skin 
atrophy in the middle chest region, with an additional few small, 
round patches bellow the nipple on both sides in one girl. Diag-
nosis of IAOP was based on characteristic clinical findings. IAOP is 
rare, benign, but permanent skin injury in the most immature of 
infants, with a potential for considerable aesthetic and psycho-
logical burden. Due to the constant increase in survival of very 
and extremely preterm infants, more often without major devel-
opmental consequences, milder complications like IAOP will be-
come more and more important. 
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INTRODUCTION
Iatrogenic anetoderma of prematurity (IAOP) 
represents a benign iatrogenic dermatosis charac-
terized by focal, well-demarcated areas of atrophic 
skin in preterm infants. Skin atrophy occurs due to 
local loss of dermal elastic fibers. IAOP primarily af-
fects the most immature infants (1). Having in mind 
the ever-increasing rate of birth and survival of very 
and extremely preterm infants, we can expect a 
growing number of children with skin changes that 
correspond to IAOP. Although the condition is con-
sidered benign, it is permanent, with aesthetic and 
sometimes disfiguring effects. IAOP is rarely reported 
in the literature. 
CASE REPORTS
We present the cases of 5 infants diagnosed 
with IAOP during a 3-year period (January 2015 
– December 2017) in a single tertiary-care university 
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hospital. Data about their prenatal history, birth, pri-
mary hospitalization, and follow-up were retrospec-
tively collected from their medical records. In all pre-
sented infants, skin atrophy patches were absent at 
birth, and there was no family history of anetoderma. 
Skin biopsy was not performed in any of the cases, 
and diagnosis of IAOP was based on characteristic 
clinical findings.
All of the infants were born at a very low gesta-
tional age; four of them were less than 26 gestational 
weeks (GW) old, and one was 30 GW old but with a 
congenital heart defect (pentalogy Fallot) which was 
surgically treated at an early age (4 months). All of 
them also had very low birth weight (BW) (four ex-
tremely preterm infants <800g at birth), but within 
eutrophic range for their gestational age. One infant 
was male and four were female, all from single preg-
nancies. The clinical course was complicated in all 
cases with the need for resuscitation at birth, endo-
tracheal intubation, and ventilation, with subsequent 
development of bronchopulmonal dysplasia in four 
extremely preterm infants. Each of the presented in-
fants also developed several other prematurity-relat-
ed complications: late-onset sepsis in all five infants, 
hemodynamically important patent duct in 3 infants, 
severe retinopathy of prematurity in 3 infants, and 
severe intracranial hemorrhage in 2 infants (in a boy 
treated with ventriculo-peritoneal shunt). Addition-
ally, all had very long primary hospitalizations. The 
most important perinatal and neonatal characteris-
tics of the infants are shown in Table 1.
These perinatal-neonatal data illustrate the com-
plicated clinical course in the presented infants, with 
long periods of unstable vital functions and a need 
for continuous monitoring. All the infants were moni-
tored with use of ECG electrodes for a lengthy period 
of time. In all the cases, skin defects consistent with 
IAOP were located on previous electrode sites. In four 
infants, IAOP emerged as a single oval patch of skin 
atrophy in the middle chest region. In patient num-
ber 2, an extremely preterm girl, IAOP changes were 
much more extensive, with irregular heart-shape 
atrophic skin in the middle of the décolleté and a few 
smaller round patches bellow the nipple on both sides 
(Figure 1). In all our cases, IAOP emerged at the age of 
3-5 postnatal months, with preceding skin changes. 
In patient 3, round hyperpigmentation on a previous 
electrode site was noticed initially, after which a tel-
angiectatic area emerged, that gradually transformed 
into an atrophic lesion (Figure 2). In patient 5 there 
was an oval area of redness prior to fully-developed 
IAOP. In the remaining three patients, regions of red-
ness with few small skin-damaged areas and scabs 
were noticed initially and subsequently converted 
into IAOP lesions (Figure 3). In all presented cases, 
the permanent IAOP changes developed in the form 
of atrophic hypopigmented regions surrounded by 
hyperpigmented edges. On follow-up examinations, 
which were performed until the age of 12-30 months, 
IAOP lesions remained unchanged, with a slight in-
crease in size parallel to infant body-growth.
Table 1. Perinatal and neonatal characteristics of presented infants diagnosed with iatrogenic  
anetoderma of prematurity
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Gestation (weeks) 25 24+5 24+5 25+4 30
Birth weight (grams) 780 750 680 670 1270
Appropriate for gestational age yes yes yes yes yes
Sex girl girl boy girl girl
Mechanical ventilation yes yes yes yes yes
Bronchopulmonal dysplasia yes yes yes yes yes
Late-onset sepsis yes yes yes yes yes
Treated patent duct no yes yes yes /
Severe intracranial hemorrhage yes no yes no no
Severe retinopathy of prematurity no yes yes yes no
Congenital malformations no no no no Pentalogy Fallot
Length of primary hospitalization (days) 108 96 174 222 149
1
Figure 1 Extensive atrophic skin changes in patient No 2
Figure 1. Extensive atrophic skin changes in patient No 2.
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During the 3-year study period, 239 very and ex-
tremely preterm infants, i.e. with less than 32 GW of 
age, were discharged from our hospital. Since 5 of 
them developed IAOP, the frequency of this type of 
skin lesions was 2.09% among infants in this subpop-
ulation.
DISCUSSION
Anetoderma can generally occur at any age. The 
occurrence of anetoderma in infants can be congeni-
tal (present at birth), familial (present in family mem-
bers, immerged at birth, or presenting spontaneously 
during first decade of life), or acquired at an early age 
in very and extreme preterm infants (2,3). The latter 
refers to IAOP as a specific consequence of iatro-
genic application of various medical adhesives and 
electrodes in modern neonatal intensive care units 
(NICU) (1).  
IAOP is rarely reported in literature. The first report 
of two cases of IAOP, though under a different name 
(“skin craters”) was published in 1981 by Golden 
(4). The term “anetoderma of prematurity” was first 
introduced by Prizant et al. (5) in 1996, when the 
authors reported a series of 9 cases of IAOP. Subse-
quently, 5 more cases of IAOP were published before 
2010 in a total of three papers (Todd (6) in 1997, Cold-
itz et al. (7) in 1999, and Ben-Amitai et al. (8) in 2008). 
In 2010 Goujon et al. (9) reported the largest series of 
IAOP cases. They described 11 patients born at 25-30 
weeks of gestation, with skin lesions on the ventral 
side of the trunk associated with prolonged usage of 
ECG electrodes. In 2014, Maffeis et al. (10) gave a de-
tailed description of an IAOP lesion on the chest in an 
extremely preterm girl. Finally, in 2016 Glauser et al. 
(11) reported 4 cases of IAOP changes in extremely 
preterm infants associated with ECG electrodes and 
CO2 leads. That makes a total of 32 literature cases of 
IAOP until our report.
IAOP is characterized by well-demarcated areas 
of changed skin texture and/or coloration (1). These 
areas may be flat or below the level of surrounding 
skin. Additionally, (usually in later course, with the 
child’s growth) they may emerge as pouch-like her-
niation of atrophic skin (1,10). The skin changes are 
2
Figure 2  Round telangiectatic area on previous electrode site (a) which was 
gradually transformed into atrophic lesion (b) in patient No 3
a b 
Figure 2. Round telangiectatic area on a previous electrode site (a) which was gradually transformed into an atrophic lesion 
(b) in patient No 3.
Table 2. Summarized perinatal and clinical characteristics of all infants with iatrogenic anetoderma of pre-
maturity reported so far, including our clinical cases
Gestational age (weeks) (n=37) 24-32 GW (up to 30 GW in 34=91.89%)
Birth-weight (g) (n=37) 440-1640 (< 1500g in 33 =89.19%)
SGA status (n=37) 8 (21.62%)
Single/twin (n=28) Twins 9 (32.14%)
Sex – male (n=26) 13 (50%)
Mechanical ventilation (n=37) 33 (89.19%)
Electrodes (n=37) 35 (94.59%)
Morbidity (n=37) BPD: 27 (72.97%)
PDA treatment: 17 (45.94%)
BPD – Bronchopulmonary dysplasia
PDA – Patent ductus arteriosus
Matić et al. Acta Dermatovenerol Croat
Iatrogenic anetoderma of prematurity 2020;28(2):70-74
73ACTA DERMATOVENEROLOGICA CROATICA
usually located on the ventral side of the trunk at the 
sites where electrodes or adhesives were previously 
attached to the chest and/or abdomen (4-6,8-11), but 
in some cases were located on the back (4), thighs (4), 
proximal extremities (5), and forehead (7). In all our 
presented patients, IAOP changes were located on 
the chest – in the middle chest region, with addition-
al bilateral changes in near-mamillar regions in the 
girl that has the greatest number of extensive lesions. 
Findings of IAOP above sternum might be associated 
with specific characteristics of the skin of this region 
– thin skin tightened over chest bone, with a scarce 
subcutaneous fatty tissue layer. As in most reported 
cases, these skin changes corresponded to previous 
ECG electrode sites. Most reported cases were also as-
sociated with the usage of different electrodes, either 
ECG (5,6,9-11), transcutaneous O2 and CO2 (4,11) or 
EEG electrodes (7). Usually, although not necessar-
ily, different preceding skin changes can be seen on 
electrodes or adhesives sites. These take the form of 
hyperpigmentation, ecchymoses, hematoma, telan-
giectasia, or redness with or without additional skin 
damage and scabs. The lesions corresponding to fully 
developed IAOP are usually not noted immediately 
after specific skin injury, but rather after a period 
ranging from several weeks to several months (1).
The exact mechanism of developing IAOP skin 
changes, as well as anetoderma in general, has not 
yet been fully explained. Appearance of any type of 
anetoderma, i.e. loss of dermal elastic tissue, can be 
attributed to defects in synthesis and/or increased 
degradation of elastic fibers (8). In modern NICU, us-
age of medical adhesives, including different kinds 
of tapes, electrodes, dressings, and ostomy bags and 
pouches is an everyday necessity. At the same time, 
adhesives are the primary cause of a wide range of 
iatrogenic skin injuries (12-14), including IAOP. The 
proposed mechanism of occurrence of IAOP is hy-
poxia and inflammation of the local skin tissue as 
well as repetitive and long-term mechanical injury 
by pressure and traction caused by the presence and 
frequent replacement of medical adhesives (16). Pre-
ventive measures should include gentle care and ma-
nipulation of all medical adhesives, especially elec-
trodes, avoiding positioning electrodes on cosmeti-
cally sensitive areas, minimizing pressure by prevent-
ing the infant from lying on electrodes, occasionally 
changing the position of the electrodes, and usage 
of hydrogel electrodes and silicone adhesives (1,9,15-
17). Adherence to the abovementioned preventive 
measures is particularly important in infants with the 
highest risk of iatrogenic skin injuries, including per-
manent ones such as IAOP. 
Using a summary of the characteristics of previ-
ously reported infants with IAOP (although some of 
the reports do not contain all information of interest) 
with the addition of clinical cases presented in this 
paper (37 cases in total), we have tried to present a 
profile of infants at particular risk of IAOP (Table 2).
Based on the IAOP cases published so far, we can 
conclude that the greatest risk for this type of skin 
lesions is present in infants born with very and ex-
tremely low gestation and BW and with unstable vi-
tal functions from birth, whose critical condition de-
mands mechanical ventilation and long hospital stay, 
as well as prolonged continuous monitoring that in-
volves the use of different electrodes. 
Contemporary neonatology is not aimed at sur-
vival alone, but rather on the long-term quality of life 
even in infants born at the lower limit of viability. At 
first glance, IAOP changes can seem irrelevant in in-
fants with such a high risk of mortality and different 
major morbidities. But more and more these infants 
not only survive but also have no major long-term 
3
Figure 3  Erythematous area in the middle chest region on previous electrode 
site (a) with later conversion into IAOP lesion (b) in patient No 4
a b
Figure 3. Erythematous area in the middle chest region on a previous electrode site (a) with later conversion into an IAOP 
lesion (b) in patient No 4.
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health and developmental consequences caused by 
prematurity. After the first several years of life, when 
the focus is on following up these major morbidities, 
more subtle complications can become important in 
later developmental stages, especially at school-age 
and in adolescence. IAOP changes are permanent, 
and for the time being there is no treatment other 
than surgery. IAOP can cause significant aesthetic and 
consequently psychological burden. For example, our 
patient 2 is a girl with rather extensive IAOP changes. 
She was followed during 30 months of postnatal age, 
and her psycho-motor development is even slightly 
above average compared with her term peers. But 
the aesthetic consequences of her IAOP are unavoid-
able. It is yet to be seen whether there may be skin 
outpouching in the near-mamillar regions during 
puberty with the onset of breast development, and 
how heavy a psychological burden will be created by 
those skin changes.
CONCLUSION
IAOP is a benign but permanent skin injury, with 
a potentially considerable aesthetic and consequent 
psychological burden. It occurs in very and extremely 
preterm infants. Given the increasing survival of these 
infants, more and more often without major develop-
mental consequences, milder complications like IAOP 
will become even more important. Different profiles 
of health workers should be familiar with IAOP in or-
der to prevent, recognize, and provide proper advice 
to children with IAOP as well as their parents.
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